Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. It is typically
fatal within 2–5 years of symptom onset. The incidence of ALS is largely uniform across most …

The scientific scenario of amyotrophic lateral sclerosis (ALS) has dramatically changed
since TDP-43 aggregates were discovered in 2006 as the main component of the neuronal …

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) or motor neuron disease is a rapidly
progressive neurodegenerative disorder. The primary involvement is of motor neurons in the …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor
neurons, resulting in worsening weakness of voluntary muscles until death occurs from …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects central
and peripheral motor neuron cells. Its etiology is unknown, although a relationship between …

The objective of our study was to perform a randomized controlled trial (RCT) aimed to
evaluate the effects of three strictly monitored exercise programs (SMEP) compared to …

As the population ages, the incidence and prevalence of neurodegenerative disorders will
continue to increase. Persons with neurodegenerative disease frequently experience sleep …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease primarily affecting the
upper and lower motor neurons. The lifetime risk of developing ALS is estimated at 1: 350 for …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no known
cure. Approximately 90% of ALS cases are sporadic, although multiple genetic risk factors …

ALS is a relentlessly progressive and fatal disease, with no curative therapies available to
date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains …